Literature DB >> 23392265

[Genetics of idiopathic epilepsies].

Y G Weber1, H Lerche.   

Abstract

Idiopathic epilepsies are genetically determined. They are characterized by the observed seizure types, an age-dependent onset, electroencephalographic criteria and concomitant symptoms, such as movement disorders or developmental delay. The main subtypes are the idiopathic (i) generalized, (ii) the focal epilepsies including the benign syndromes of early childhood and (iii) the epileptic encephalopathies as well as the fever-associated syndromes. In recent years, an increasing number of mutations have been identified in genes encoding ion channels, proteins associated to the vesical synaptic cycle or proteins involved in energy metabolism. These mechanisms are pathophysiologically plausible as they influence neuronal excitability. The large number of genetic defects in epilepsy complicates the genetic diagnostic analysis but novel genetic methods are available covering all known genes at a reasonable price. The proof of a genetic defect leads to a definitive diagnosis, is important for the prognostic and genetic counselling and may influence therapeutic decisions in some cases, so that genetic diagnostic testing is becoming increasingly more important and meaningful in many cases in daily clinical practice.

Entities:  

Mesh:

Year:  2013        PMID: 23392265     DOI: 10.1007/s00115-012-3639-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  29 in total

1.  KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.

Authors:  Sarah Weckhuysen; Simone Mandelstam; Arvid Suls; Dominique Audenaert; Tine Deconinck; Lieve R F Claes; Liesbet Deprez; Katrien Smets; Dimitrina Hristova; Iglika Yordanova; Albena Jordanova; Berten Ceulemans; An Jansen; Danièle Hasaerts; Filip Roelens; Lieven Lagae; Simone Yendle; Thorsten Stanley; Sarah E Heron; John C Mulley; Samuel F Berkovic; Ingrid E Scheffer; Peter de Jonghe
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

2.  GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy.

Authors:  P Striano; Y G Weber; M R Toliat; J Schubert; C Leu; R Chaimana; S Baulac; R Guerrero; E LeGuern; A-E Lehesjoki; A Polvi; A Robbiano; J M Serratosa; R Guerrini; P Nürnberg; T Sander; F Zara; H Lerche; C Marini
Journal:  Neurology       Date:  2012-01-25       Impact factor: 9.910

3.  Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy.

Authors:  Yunxiang Liao; Liesbet Deprez; Snezana Maljevic; Julika Pitsch; Lieve Claes; Dimitrina Hristova; Albena Jordanova; Sirpa Ala-Mello; Astrid Bellan-Koch; Dragica Blazevic; Simone Schubert; Evan A Thomas; Steven Petrou; Albert J Becker; Peter De Jonghe; Holger Lerche
Journal:  Brain       Date:  2010-04-05       Impact factor: 13.501

4.  Targeted next generation sequencing as a diagnostic tool in epileptic disorders.

Authors:  Johannes R Lemke; Erik Riesch; Tim Scheurenbrand; Max Schubach; Christian Wilhelm; Isabelle Steiner; Jörg Hansen; Carolina Courage; Sabina Gallati; Sarah Bürki; Susi Strozzi; Barbara Goeggel Simonetti; Sebastian Grunt; Maja Steinlin; Michael Alber; Markus Wolff; Thomas Klopstock; Eva C Prott; Rüdiger Lorenz; Christiane Spaich; Sabine Rona; Maya Lakshminarasimhan; Judith Kröll; Thomas Dorn; Günter Krämer; Matthis Synofzik; Felicitas Becker; Yvonne G Weber; Holger Lerche; Detlef Böhm; Saskia Biskup
Journal:  Epilepsia       Date:  2012-05-21       Impact factor: 5.864

5.  Sodium-channel defects in benign familial neonatal-infantile seizures.

Authors:  Sarah E Heron; Kathryn M Crossland; Eva Andermann; Hilary A Phillips; Allison J Hall; Andrew Bleasel; Michael Shevell; Suha Mercho; Marie-Helene Seni; Marie-Christine Guiot; John C Mulley; Samuel F Berkovic; Ingrid E Scheffer
Journal:  Lancet       Date:  2002-09-14       Impact factor: 79.321

6.  Autosomal dominant nocturnal frontal lobe epilepsy with a mutation in the CHRNB2 gene.

Authors:  Fernando Díaz-Otero; Mar Quesada; José Morales-Corraliza; Carlos Martínez-Parra; Pilar Gómez-Garre; José M Serratosa
Journal:  Epilepsia       Date:  2007-09-26       Impact factor: 5.864

7.  A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.

Authors:  A G Marson; R Appleton; G A Baker; D W Chadwick; J Doughty; B Eaton; C Gamble; A Jacoby; P Shackley; D F Smith; C Tudur-Smith; A Vanoli; P R Williamson
Journal:  Health Technol Assess       Date:  2007-10       Impact factor: 4.014

Review 8.  Genetic mechanisms in idiopathic epilepsies.

Authors:  Yvonne G Weber; Holger Lerche
Journal:  Dev Med Child Neurol       Date:  2008-09       Impact factor: 5.449

9.  Two novel CLCN2 mutations accelerating chloride channel deactivation are associated with idiopathic generalized epilepsy.

Authors:  Cécile Saint-Martin; Grégory Gauvain; Georgeta Teodorescu; Isabelle Gourfinkel-An; Estelle Fedirko; Yvonne G Weber; Snezana Maljevic; Jan-Peter Ernst; Jennie Garcia-Olivares; Christoph Fahlke; Rima Nabbout; Eric LeGuern; Holger Lerche; Jean Christophe Poncer; Christel Depienne
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

10.  Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear.

Authors:  Paolo Aridon; Carla Marini; Chiara Di Resta; Elisa Brilli; Maurizio De Fusco; Fausta Politi; Elena Parrini; Irene Manfredi; Tiziana Pisano; Dario Pruna; Giulia Curia; Carlo Cianchetti; Massimo Pasqualetti; Andrea Becchetti; Renzo Guerrini; Giorgio Casari
Journal:  Am J Hum Genet       Date:  2006-06-26       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.